Enzyme replacement therapy is a medical treatment that can replace the lack of or missing enzymes in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme. ERT can be used for certain lysosomal storage diseases: Gaucher's disease, Fabry disease, MPS I, MPS II, MPS VI and Pompe disease. ERT cannot correct underlying genetic defects, but it will increase the concentration of enzymes that the patient lacks.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Therapeutic Enzymes industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Injectable
Oral
Topical
Market Segment by Product Application
Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Digestive Care
Leadiant Biosciences
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Therapeutic Enzymes consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Therapeutic Enzymes market by identifying its various subsegments.
3.Focuses on the key global Therapeutic Enzymes manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Therapeutic Enzymes with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Therapeutic Enzymes submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Therapeutic Enzymes Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Therapeutic Enzymes Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Therapeutic Enzymes Segment by Type
2.1.1 Injectable
2.1.2 Oral
2.1.3 Topical
2.2 Market Analysis by Application
2.2.1 Gaucher Disease
2.2.2 MPS Disease
2.2.3 Gastrointestinal Diseases
2.2.4 Others
2.3 Global Therapeutic Enzymes Market Comparison by Regions (2017-2027)
2.3.1 Global Therapeutic Enzymes Market Size (2017-2027)
2.3.2 North America Therapeutic Enzymes Status and Prospect (2017-2027)
2.3.3 Europe Therapeutic Enzymes Status and Prospect (2017-2027)
2.3.4 China Therapeutic Enzymes Status and Prospect (2017-2027)
2.3.5 Japan Therapeutic Enzymes Status and Prospect (2017-2027)
2.3.6 Southeast Asia Therapeutic Enzymes Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Therapeutic Enzymes Industry Impact
2.5.1 Therapeutic Enzymes Business Impact Assessment - Covid-19
2.5.2 Market Trends and Therapeutic Enzymes Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Therapeutic Enzymes Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Therapeutic Enzymes Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Therapeutic Enzymes Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Therapeutic Enzymes Manufacturer Market Share
3.5 Top 10 Therapeutic Enzymes Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Therapeutic Enzymes Market
3.7 Key Manufacturers Therapeutic Enzymes Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Therapeutic Enzymes Industry Key Manufacturers
4.1 Sanofi
4.1.1 Compan Detail
4.1.2 Sanofi Therapeutic Enzymes Product Introduction, Application and Specification
4.1.3 Sanofi 162 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Sanofi News
4.2 BioMarin
4.2.1 Compan Detail
4.2.2 BioMarin Therapeutic Enzymes Product Introduction, Application and Specification
4.2.3 BioMarin Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Sanofi News
4.3 AbbVie
4.3.1 Compan Detail
4.3.2 AbbVie Therapeutic Enzymes Product Introduction, Application and Specification
4.3.3 AbbVie Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 AbbVie News
4.4 Shire
4.4.1 Compan Detail
4.4.2 Shire Therapeutic Enzymes Product Introduction, Application and Specification
4.4.3 Shire Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Shire News
4.5 Alexion
4.5.1 Compan Detail
4.5.2 Shire Therapeutic Enzymes Product Introduction, Application and Specification
4.5.3 Alexion Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Alexion News
4.6 Horizon Pharma
4.6.1 Compan Detail
4.6.2 Horizon Pharma Therapeutic Enzymes Product Introduction, Application and Specification
4.6.3 Horizon Pharma Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Horizon Pharma News
4.7 Allergan
4.7.1 Compan Detail
4.7.2 Allergan Therapeutic Enzymes Product Introduction, Application and Specification
4.7.3 Allergan Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Johnson & Johnson
4.8.1 Compan Detail
4.8.2 Johnson & Johnson Therapeutic Enzymes Product Introduction, Application and Specification
4.8.3 Johnson & Johnson Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Johnson & Johnson News
4.9 Recordati Rare Diseases
4.9.1 Compan Detail
4.9.2 Recordati Rare Diseases Therapeutic Enzymes Product Introduction, Application and Specification
4.9.3 Recordati Rare Diseases Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Recordati Rare Diseases News
4.10 Pfizer
4.10.1 Compan Detail
4.10.2 Pfizer Therapeutic Enzymes Product Introduction, Application and Specification
4.10.3 Pfizer Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Pfizer News
4.11 Vivus
4.11.1 Compan Detail
4.11.2 Vivus Therapeutic Enzymes Product Introduction, Application and Specification
4.11.3 Vivus Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Vivus News
4.12 Digestive Care
4.12.1 Compan Detail
4.12.2 Digestive Care Therapeutic Enzymes Product Introduction, Application and Specification
4.12.3 Digestive Care Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Digestive Care News
4.13 Leadiant Biosciences
4.13.1 Company Details
4.13.2 Leadiant Biosciences Therapeutic Enzymes Product Introduction, Application and Specification
4.13.3 Leadiant Biosciences Therapeutic Enzymes Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Leadiant Biosciences News
5 Global Therapeutic Enzymes Market Segment by Big Type
5.1 Global Therapeutic Enzymes Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Therapeutic Enzymes Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Therapeutic Enzymes Revenue and Market Share by Big Type (2017-2022)
5.2 Injectable Sales Growth Rate and Price
5.2.1 Global Injectable Sales Growth Rate (2017-2022)
5.2.2 Global Injectable Price (2017-2022)
5.3 Oral Sales Growth Rate and Price
5.3.1 Global Oral Sales Growth Rate (2017-2022)
5.3.2 Global Oral Price (2017-2022)
5.4 Topical Sales Growth Rate and Price
5.4.1 Global Topical Sales Growth Rate (2017-2022)
5.4.2 Global Topical Price (2017-2022)
6 Global Therapeutic Enzymes Market Segment by Big Application
6.1 Global Therapeutic Enzymes Sales Market Share by Big Application (2017-2022)
6.2 Gaucher Disease Sales Growth Rate (2017-2022)
6.3 MPS Disease Sales Growth Rate (2017-2022)
6.4 Gastrointestinal Diseases Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global Therapeutic Enzymes Forecast
7.1 Global Therapeutic Enzymes Revenue, Sales and Growth Rate (2022-2027)
7.2 Therapeutic Enzymes Market Forecast by Regions (2022-2027)
7.2.1 North America Therapeutic Enzymes Market Forecast (2022-2027)
7.2.2 Europe Therapeutic Enzymes Market Forecast (2022-2027)
7.2.3 China Therapeutic Enzymes Market Forecast (2022-2027)
7.2.4 Japan Therapeutic Enzymes Market Forecast (2022-2027)
7.2.5 Southeast Asia Therapeutic Enzymes Market Forecast (2022-2027)
7.2.6 Other Regions Therapeutic Enzymes Market Forecast (2022-2027)
7.3 Therapeutic Enzymes Market Forecast by Type (2022-2027)
7.3.1 Global Therapeutic Enzymes Sales Forecast by Type (2022-2027)
7.3.2 Global Therapeutic Enzymes Market Share Forecast by Type (2022-2027)
7.4 Therapeutic Enzymes Market Forecast by Application (2022-2027)
7.4.1 Global Therapeutic Enzymes Sales Forecast by Application (2022-2027)
7.4.2 Global Therapeutic Enzymes Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Therapeutic Enzymes Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Therapeutic Enzymes Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Therapeutic Enzymes
Figure Market Concentration Ratio and Market Maturity Analysis of Therapeutic Enzymes
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Therapeutic Enzymes Market Size by Big Type
Figure Global Market Share of Therapeutic Enzymes by Big Type in 2021
Figure Injectable Picture (2017-2022)
Figure Oral Picture (2017-2022)
Global Therapeutic Enzymes Market Size by Big Application
Table Global Therapeutic Enzymes Market Size by Application
Figure Global Therapeutic Enzymes Market Share by Big Application in 2021
Figure Gaucher Disease Picture
Figure MPS Disease Picture
Figure Gastrointestinal Diseases Picture
Figure Others Picture
Table Global Therapeutic Enzymes Comparison by Regions (M USD) (2017-2027)
Figure Global Therapeutic Enzymes Market Size (Million US$) (2017-2027)
Figure North America Therapeutic Enzymes Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Therapeutic Enzymes Revenue (Million US$) Growth Rate (2017-2027)
Figure China Therapeutic Enzymes Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Therapeutic Enzymes Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Therapeutic Enzymes Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Therapeutic Enzymes Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Therapeutic Enzymes Sales by Manufacturer (2017-2022)
Figure Global Therapeutic Enzymes Sales Market Share by Manufacturer in 2021
Table Global Therapeutic Enzymes Revenue by Manufacturer (2017-2022)
Figure Global Therapeutic Enzymes Revenue Market Share by Manufacturer in 2021
Table Global Therapeutic Enzymes Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Therapeutic Enzymes Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Therapeutic Enzymes Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Therapeutic Enzymes Market
Table Key Manufacturers Therapeutic Enzymes Product Type
Table Mergers & Acquisitions Planning
Table Sanofi Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Sanofi
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table BioMarin Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of BioMarin
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table BioMarin Recent Development
Table AbbVie Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of AbbVie
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AbbVie Main Business
Table AbbVie Recent Development
Table Shire Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Shire
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shire Main Business
Table Shire Recent Development
Table Shire Main Business
Table Shire Recent Development
Table Alexion Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Alexion
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alexion Main Business
Table Alexion Recent Development
Table Horizon Pharma Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Horizon Pharma
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Horizon Pharma Main Business
Table Horizon Pharma Recent Development
Table Allergan Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Allergan
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Allergan Main Business
Table Allergan Recent Development
Table Johnson & Johnson Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Johnson & Johnson
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Recordati Rare Diseases Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Recordati Rare Diseases
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Recordati Rare Diseases Main Business
Table Recordati Rare Diseases Recent Development
Table Pfizer Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Pfizer
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Vivus Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Vivus
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Vivus Main Business
Table Vivus Recent Development
Table Digestive Care Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Digestive Care
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Digestive Care Main Business
Table Digestive Care Recent Development
Table Leadiant Biosciences Company Profile
Table Therapeutic Enzymes Product Introduction, Application and Specification of Leadiant Biosciences
Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Leadiant Biosciences Main Business
Table Leadiant Biosciences Recent Development
Figure Global Therapeutic Enzymes Sales and Growth Rate (2017-2022)
Figure Global Therapeutic Enzymes Revenue and Growth Rate (2017-2022)
Table Global Therapeutic Enzymes Sales by Regions (2017-2022)
Figure Global Therapeutic Enzymes Sales Market Share by Regions in 2021
Table Global Therapeutic Enzymes Revenue by Regions (2017-2022)
Figure Global Therapeutic Enzymes Revenue Market Share by Regions in 2021
Figure North America Therapeutic Enzymes Sales and Growth Rate (2017-2022)
Figure Europe Therapeutic Enzymes Sales and Growth Rate (2017-2022)
Figure China Therapeutic Enzymes Sales and Growth Rate (2017-2022)
Figure Japan Therapeutic Enzymes Sales and Growth Rate (2017-2022)
Figure Southeast Asia Therapeutic Enzymes Sales and Growth Rate (2017-2022)
Figure Other Regions Therapeutic Enzymes Sales and Growth Rate (2017-2022)
Table Global Therapeutic Enzymes Sales by Big Type (2017-2022)
Table Global Therapeutic Enzymes Sales Market Share by Big Type (2017-2022)
Figure Global Therapeutic Enzymes Sales Market Share by Big Type in 2019
Table Global Therapeutic Enzymes Revenue by Big Type (2017-2022)
Table Global Therapeutic Enzymes Revenue Market Share by Big Type (2017-2022)
Table Global Therapeutic Enzymes Revenue Market Share by Big Type in 2019
Figure Global Injectable Sales Growth Rate (2017-2022)
Figure Global Injectable Price (2017-2022)
Figure Global Oral Sales Growth Rate (2017-2022)
Figure Global Oral Price (2017-2022)
Figure Global Topical Sales Growth Rate (2017-2022)
Table Global Therapeutic Enzymes Sales by Big Application (2017-2022)
Table Global Therapeutic Enzymes Sales Market Share by Big Application (2017-2022)
Figure Global Therapeutic Enzymes Sales Market Share by Big Application in 2019
Figure Global Gaucher Disease Sales Growth Rate (2017-2022)
Figure Global MPS Disease Sales Growth Rate (2017-2022)
Figure Global Gastrointestinal Diseases Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Therapeutic Enzymes Sales and Growth Rate (2022-2027)
Figure Global Therapeutic Enzymes Revenue and Growth Rate (2022-2027)
Table Global Therapeutic Enzymes Sales Forecast by Regions (2022-2027)
Table Global Therapeutic Enzymes Market Share Forecast by Regions (2022-2027)
Figure North America Sales Therapeutic Enzymes Market Forecast (2022-2027)
Figure Europe Sales Therapeutic Enzymes Market Forecast (2022-2027)
Figure China Sales Therapeutic Enzymes Market Forecast (2022-2027)
Figure Japan Sales Therapeutic Enzymes Market Forecast (2022-2027)
Figure Southeast Asia Sales Therapeutic Enzymes Market Forecast (2022-2027)
Figure Other Regions Sales Therapeutic Enzymes Market Forecast (2022-2027)
Table Global Therapeutic Enzymes Sales Forecast by Type (2022-2027)
Table Global Therapeutic Enzymes Market Share Forecast by Type (2022-2027)
Table Global Therapeutic Enzymes Sales Forecast by Application (2022-2027)
Table Global Therapeutic Enzymes Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Enzymes
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Therapeutic Enzymes Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Therapeutic Enzymes Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Therapeutic Enzymes Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Therapeutic Enzymes Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Therapeutic Enzymes Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Therapeutic Enzymes Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Therapeutic Enzymes Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Therapeutic Enzymes Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)